Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer

In this randomized phase 3 trial involving patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not involve the use of radioiodine was noninferior to the use of radioiodine in the response to treatment at 3 years.

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 386; no. 10; pp. 923 - 932
Main Authors Leboulleux, Sophie, Bournaud, Claire, Chougnet, Cecile N., Zerdoud, Slimane, Al Ghuzlan, Abir, Catargi, Bogdan, Do Cao, Christine, Kelly, Antony, Barge, Marie-Luce, Lacroix, Ludovic, Dygai, Inna, Vera, Pierre, Rusu, Daniela, Schneegans, Olivier, Benisvy, Danielle, Klein, Marc, Roux, Julie, Eberle, Marie-Claude, Bastie, Delphine, Nascimento, Camila, Giraudet, Anne-Laure, Le Moullec, Nathalie, Bardet, Stéphane, Drui, Delphine, Roudaut, Nathalie, Godbert, Yann, Morel, Olivier, Drutel, Anne, Lamartina, Livia, Schvartz, Claire, Velayoudom, Fritz-Line, Schlumberger, Martin-Jean, Leenhardt, Laurence, Borget, Isabelle
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 10.03.2022
Subjects
Online AccessGet full text
ISSN0028-4793
1533-4406
1533-4406
DOI10.1056/NEJMoa2111953

Cover

More Information
Summary:In this randomized phase 3 trial involving patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not involve the use of radioiodine was noninferior to the use of radioiodine in the response to treatment at 3 years.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa2111953